Thank you for your interest in participating in the Task Force on Gastrointestinal Issues in Parkinson’s Disease. Please complete the following form to document your interest and credentials. Completed forms are due by Friday, October 9.
This Task Force will systematically review the evidence on ways that GI issues (gastroparesis, constipation, and small-intestinal bacterial overgrowth) affect the bioavailability of oral/enteral antiparkinsonian medication; obtain expert opinions on diagnostic and therapeutic strategies for GI issues in PD to inform new clinical recommendations; and subsequently publish review findings and MDS Expert Recommendations for diagnosis and treatment, with priority first submission to the Movement Disorders Journal.